BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 10797988)

  • 1. [Protein C, protein S and antithrombin III at normal delivery and during abruptio placentae].
    Thiam D; Diop S; Ba Gueye M; Fall K; Toure AO; Diadhiou F; Diakhate L
    Dakar Med; 1999; 44(1):54-7. PubMed ID: 10797988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein C, protein S and antithrombin III levels in the course of bone marrow and subsequent liver transplantation due to veno-occlusive disease.
    Salat C; Holler E; Göhring P; Poley S; Kolb HJ; Pihusch R; Reinhardt B; Krämling HJ; Haller M; Hiller E
    Eur J Med Res; 1996 Nov; 1(12):571-4. PubMed ID: 9438165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of recombinant human erythropoietin on physiological inhibitors of coagulation in children on continuous ambulatory peritoneal dialysis.
    Kisaarslan FA; Gündüz Z; Düsünsel R; Poyrazoglu HM; Saraymen R; Elmas B
    Adv Perit Dial; 1999; 15():273-7. PubMed ID: 10682117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of protein C, protein S, and antithrombin III in acute leukemia.
    Dixit A; Kannan M; Mahapatra M; Choudhry VP; Saxena R
    Am J Hematol; 2006 Mar; 81(3):171-4. PubMed ID: 16493609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin treatment in abruptio placentae.
    Martin TR; Read HC; Fraser ME
    Can Med Assoc J; 1974 May; 110(10):1159-64. PubMed ID: 4829841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Alterations in coagulation and fibrinolytic system in abruptio placentae (author's transl)].
    Saito H
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Apr; 34(4):529-37. PubMed ID: 7069257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normal activities of protein C, protein S and antithrombin III in young patients with retinal vein occlusion.
    Guareschi G; Viganò D'Angelo S; Foresti V; Bandello F; D'Angelo A
    Haematologica; 1990; 75(5):483-4. PubMed ID: 2151449
    [No Abstract]   [Full Text] [Related]  

  • 8. Abruptio placentae and disseminated intravascular coagulation.
    Gilabert J; Estelles A; Aznar J; Galbis M
    Acta Obstet Gynecol Scand; 1985; 64(1):35-9. PubMed ID: 3976375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of protein C, protein S, and antithrombin III in newborns with sepsis.
    El Beshlawy A; Alaraby I; Abou Hussein H; Abou-Elew HH; Mohamed Abdel Kader MS
    Pediatr Crit Care Med; 2010 Jan; 11(1):52-9. PubMed ID: 19924026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expanded blood coagulation screening--a necessity in diagnosis and therapy of thrombosis?].
    Wozniak G; Montag H; Alemany J
    Vasa Suppl; 1992; 35():92-3. PubMed ID: 1481078
    [No Abstract]   [Full Text] [Related]  

  • 11. Parameters of haemostasis during acute venous thrombosis.
    Reiter W; Ehrensberger H; Steinbrückner B; Keller F
    Thromb Haemost; 1995 Aug; 74(2):596-601. PubMed ID: 8584990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of protein C, protein S, and antithrombin III in hypoxic newborns.
    El Beshlawy A; Hussein HA; Abou-Elew HH; Abdel Kader MS
    Pediatr Crit Care Med; 2004 Mar; 5(2):163-6. PubMed ID: 14987347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Coagulation inhibitors in patients with neoplasms].
    Páramo JA; Cuesta B; Hernández M; Fernández J; Paloma MJ; Rifón J; Rocha E
    Med Clin (Barc); 1989 Feb; 92(5):164-6. PubMed ID: 2524631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coagulation inhibitors in preeclamptic pregnant women.
    Osmanağaoğlu MA; Topçuoğlu K; Ozeren M; Bozkaya H
    Arch Gynecol Obstet; 2005 Mar; 271(3):227-30. PubMed ID: 14735372
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Changes in coagulation inhibitors (AT III, protein C, protein S) in patients with liver cirrhosis].
    Kobayashi I; Kurihara A; Hamaoka S; Amemiya N; Endo T; Okuyama K
    Rinsho Byori; 1989 Apr; Spec No 81():93-7. PubMed ID: 2526888
    [No Abstract]   [Full Text] [Related]  

  • 16. Performance goals for the laboratory testing of antithrombin, protein C and protein S.
    Meijer P; Haverkate F; Kluft C
    Thromb Haemost; 2006 Nov; 96(5):584-9. PubMed ID: 17080214
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Disorders of anticoagulation and fibrinolysis in monoclonal gammopathies--another mechanism of paraprotein interference with hemostasis].
    Spicka I; Cieslar P; Hrkal Z; Fortová H; Simonianová E; Zounar R; Klener P
    Sb Lek; 1996; 97(3):369-75. PubMed ID: 9235617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [May (must?) in a for recurrent thrombophlebitis [with normal AT III/ protein C+S] fully "marcumarized" patient (with [otherwise?] negative contraindications) with acute posterior wall infarct (15 min "old") a brief lysis therapy be instituted?].
    Seitz R
    Internist (Berl); 1995 Dec; 36(12):1202. PubMed ID: 8567228
    [No Abstract]   [Full Text] [Related]  

  • 19. Circadian variations in natural coagulation inhibitors protein C, protein S and antithrombin in healthy men: a possible association with interleukin-6.
    Undar L; Ertuğrul C; Altunbaş H; Akça S
    Thromb Haemost; 1999 Apr; 81(4):571-5. PubMed ID: 10235441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Estimation of plasma protein C, protein S and antithrombin III in patients with chronic liver diseases and its clinical significance].
    Tang ZD; Wang XF; Hu XE
    Zhonghua Nei Ke Za Zhi; 1989 Dec; 28(12):722-4, 767-8. PubMed ID: 2534591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.